This reagent is for in vitro diagnostic use. Pax-5 (1EW) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of human Pax-5 in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated Bond system.
Publicado el 2 de marzo de 2016 · Inicio del retiro: 30 de diciembre de 2015
Resumen
FDA registra el retiro Z-0823-2016 de dispositivos médicos de Clase II, publicado el 2 de marzo de 2016 e iniciado el 30 de diciembre de 2015. Empresa responsable: Leica Microsystems, Inc.; Estado: Finalizado; Cantidad reportada: 1700 units; Lote: Product Code/Name: PA0552 (All Lots) Bond Ready-to-Use Primary Antibody PAX-5 (1EW). Detection Kit: DS9800 BondTM Polymer Refine Detection Kit. Affected Detection Kit Lots: 42314, 42388, 42474, 42486, 42499, 42555, 42570, 42579, 42627, 42645, 42683, 42780, 42802, 42823, 42852, 43050. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
The Bond" Polymer Refine Detection and Novolink" Polymer Detection System may not provide adequate staining when using a detection protocol where one of its components - Peroxide Block / Peroxidase Block is applied after the primary marker incubation as specified in the Instructions for Use Following the Instructions for Use.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Leica Microsystems, Inc.
- Distribuidor
- US Consignees incluude: AR ,AZ ,CA ,CO ,CT ,DC ,DE ,FL ,GA ,HI ,IA ,IL ,KY ,LA ,MA ,MD ,MI ,MN ,MO ,MT ,NC ,NH ,NJ ,NY ,OH ,OK ,PA ,PR ,SC ,TN ,TX ,UT ,VA ,VT ,WA ,WI and WV. Foreign Consignees include:Argentina , Australia , Brazil , Bulgaria , Chile , China , Ecuador ,Egypt , El Salvador , Finland , France , Georgia , Germany , Greece , India , Italy , Japan , Jordan , Kuwait , Lebanon , Malaysia , Philippines , Poland , Portugal , Romania , Russian Fed. , Singapore , South Korea , Spain , Sweden , Switzerland , Thailand , Tunisia , Turkey , United Kingdom and United Arab Emirates.
- Lote
- Product Code/Name: PA0552 (All Lots) Bond Ready-to-Use Primary Antibody PAX-5 (1EW). Detection Kit: DS9800 BondTM Polymer Refine Detection Kit. Affected Detection Kit Lots: 42314, 42388, 42474, 42486, 42499, 42555, 42570, 42579, 42627, 42645, 42683, 42780, 42802, 42823, 42852, 43050.
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDABOND Ready-To-Use Primary Antibody CDX2 (EP25), REF PA037522 de septiembre de 2021
- FDABOND Polymer Refine Detection Kit, Catalog No. DS9800. This detection system is for in vitro diagnostic use.18 de diciembre de 2019
- FDALeica M530 OHX Microscope System Supplied with 100 - 120 Vac.15 de agosto de 2018
- FDANussloch GmbH ASP6025 Tissue Processor12 de julio de 2017
- FDAGE Precision MPi is an all-digital multipurpose tilt-C x-ray system, intended for a multitude of diagnostic2 de marzo de 2016
- FDAEvita Infinity V500 Ventilator; Babylog Infinity VN500 Ventilator. Ventilation.2 de marzo de 2016
Preguntas sobre este retiro
¿This reagent is for in vitro diagnostic use. Pax-5 (1EW) monoclonal antibody is intended to be used for the qualitative identification by light microscopy of human Pax-5 in formalin-fixed, paraffin-embedded tissue by immunohistochemical staining using the automated Bond system. fue retirado del mercado?
Sí. FDA publicó el retiro Z-0823-2016 el 2 de marzo de 2016. Peligro reportado: The Bond" Polymer Refine Detection and Novolink" Polymer Detection System may not provide adequate staining when using a detection protocol where one of its components - Peroxide Block / Peroxidase Block is applied after the primary marker incubation as specified in the Instructions for Use Following the Instructions for Use.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter